The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
9,295
Sort by:
Plasma Protease C1-Inhibitor Treatment Market 2026
US$ 2,999.00
The Plasma Protease C1-Inhibitor Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics,...
November 2025
220 pages
Polycystic Kidney Disease Market - 2022-2031
US$ 2,999.00
The Polycystic Kidney Disease Market was valued at US$ 495 million in 2022 and is anticipated to reach US$ 769 million by 2031, at a CAGR of 0.058 from 2026 to 2032. The report delivers in-depth insig...
November 2025
219 pages
Polymyositis Drugs Market - 2023-2031
US$ 2,999.00
The Polymyositis Drugs Market was valued at US$ 103.1 million in 2023 and is anticipated to reach US$ 132.6 million by 2031, at a CAGR of 0.032 from 2026 to 2032. The report delivers in-depth insights...
November 2025
243 pages
Pompe Disease Therapeutics Market - 2022
US$ 2,999.00
The Pompe Disease Therapeutics Market was valued at USD 1.3 billion in 2022 and is anticipated to reach by , at a CAGR of 0.043 from 2026 to 2032. The report delivers in-depth insights into key market...
November 2025
200 pages
Porphyria Treatment Market 2026
US$ 2,999.00
The Porphyria Treatment Market was valued at in and is anticipated to reach by , at a CAGR of 0.092 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regiona...
November 2025
200 pages
Post Menopausal Osteoporosis Market - 2023-2031
US$ 2,999.00
The Post Menopausal Osteoporosis Market was valued at US$ 9.9 billion in 2023 and is anticipated to reach US$ 15.2 billion by 2031, at a CAGR of 0.054 from 2026 to 2032. The report delivers in-depth i...
November 2025
200 pages
Primary Hyperoxaluria Treatment Market - 2023-2031
US$ 2,999.00
The Primary Hyperoxaluria Treatment Market was valued at US$ 168.96 million in 2023 and is anticipated to reach US$ 365.49 million by 2031, at a CAGR of 0.098 from 2026 to 2032. The report delivers in...
November 2025
223 pages
Proton Pump Inhibitors Market - 2021-2031
US$ 2,999.00
The Proton Pump Inhibitors Market was valued at US$ 3.0 billion in 2021 and is anticipated to reach US$ 4.0 million by 2031, at a CAGR of 0.049 from 2026 to 2032. The report delivers in-depth insights...
November 2025
218 pages
Psoriatic Arthritis Therapeutics Market 2026
US$ 2,999.00
The Psoriatic Arthritis Therapeutics Market was valued at in and is anticipated to reach by , at a CAGR of 0.085 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, incl...
November 2025
210 pages
Ranitidine Market 2026
US$ 2,999.00
The Ranitidine Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional growth tr...
November 2025
220 pages
Renal Fanconi Syndrome Market - 2023-2031
US$ 2,999.00
The Renal Fanconi Syndrome Market was valued at US$ 576.4 million in 2023 and is anticipated to reach US$ 767.5 million by 2031, at a CAGR of 0.037 from 2026 to 2032. The report delivers in-depth insi...
November 2025
220 pages
Renal Insufficiency Market 2026
US$ 2,999.00
The Renal Insufficiency Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional...
November 2025
207 pages
Scleroderma Therapeutics Market 2026
US$ 2,999.00
The Scleroderma Therapeutics Market was valued at in and is anticipated to reach by , at a CAGR of 0.0598 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including r...
November 2025
243 pages
Scopolamine Market 2026
US$ 2,999.00
The Scopolamine Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional growth t...
November 2025
219 pages
South America Constipation Market 2026
US$ 2,999.00
The South America Constipation Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including re...
November 2025
219 pages
Spain Opioid Induced Constipation Market 2026
US$ 2,999.00
The Spain Opioid Induced Constipation Market was valued at in and is anticipated to reach by , at a CAGR of 0.044 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, inc...
November 2025
220 pages
Spinal Muscular Atrophy (SMA) Treatment Market 2026
US$ 2,999.00
The Spinal Muscular Atrophy (SMA) Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics,...
November 2025
223 pages
Systemic Lupus Erythematosus Market 2026
US$ 2,999.00
The Systemic Lupus Erythematosus Market was valued at in and is anticipated to reach by , at a CAGR of 0.073 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, includin...
November 2025
207 pages
Tapentadol Market 2026
US$ 2,999.00
The Tapentadol Market was valued at in and is anticipated to reach by , at a CAGR of 0.065 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional growth...
November 2025
243 pages
Thalassemia Market 2026
US$ 2,999.00
The Thalassemia Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional growth t...
November 2025
207 pages
Thalassemia Treatment Market 2026
US$ 2,999.00
The Thalassemia Treatment Market was valued at in and is anticipated to reach by , at a CAGR of 0.105 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regio...
November 2025
223 pages
Tramadol Drugs Market 2026
US$ 2,999.00
The Tramadol Drugs Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional growt...
November 2025
220 pages
Urea Cycle Disorder Treatment Market 2026
US$ 2,999.00
The Urea Cycle Disorder Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including...
November 2025
243 pages
Urinary Tract Infection Therapeutics Market 2026
US$ 2,999.00
The Urinary Tract Infection Therapeutics Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, in...
November 2025
200 pages
Ursodeoxycholic Acid Market - 2023-2031
US$ 2,999.00
The Ursodeoxycholic Acid Market was valued at US$ 581.17 million in 2023 and is anticipated to reach US$ 1120.55 million by 2031, at a CAGR of 0.098 from 2026 to 2032. The report delivers in-depth ins...
November 2025
219 pages
Vitamin D Therapy Market 2026
US$ 2,999.00
The Vitamin D Therapy Market was valued at in and is anticipated to reach by , at a CAGR of 0.122 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including regional...
November 2025
200 pages
Von Willebrand Disease Treatment Market - 2022-2031
US$ 2,999.00
The Von Willebrand Disease Treatment Market was valued at US$ 304.9 million in 2022 and is anticipated to reach US$ 728.1 million by 2031, at a CAGR of 0.065 from 2026 to 2032. The report delivers in-...
November 2025
220 pages
Wilsons Disease Treatment Market - 2023-2031
US$ 2,999.00
The Wilsons Disease Treatment Market was valued at US$ 598.25 million in 2023 and is anticipated to reach US$ 916.91 million by 2031, at a CAGR of 0.056 from 2026 to 2032. The report delivers in-depth...
November 2025
243 pages
Xerostomia Therapeutics Market 2026
US$ 2,999.00
The Xerostomia Therapeutics Market was valued at in and is anticipated to reach by , at a CAGR of 0.038 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including reg...
November 2025
207 pages
Iron Deficiency Anemia Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Therapy Type (Oral Iron Therapy, Parenteral Iron Therapy, Red Blood Cell Transfusion), By End User (Hospitals, Clinics, and Home Healthcare), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Iron Deficiency Anemia Therapy Market, valued at USD 5.49 Billion in 2024, is projected to experience a CAGR of 6.70% to reach USD 8.10 Billion by 2030. Iron Deficiency Anemia (IDA) Therapy...
November 2025
183 pages
Curative Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Biology Modifying Drugs, Gene Therapies, Cell Therapies), By Indication (Cancer, Musculoskeletal Disorders, Neurodegenerative Diseases, Rare Diseases, Hepatitis C, Others), By End User (Pharmaceutical Companies, Academic & Research Institutions, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Curative Therapeutics Market will grow from USD 485.21 Million in 2024 to USD 762.72 Million by 2030 at a 7.83% CAGR. Curative therapeutics encompass advanced medical interventions engineer...
November 2025
185 pages
Medication Adherence Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Hardware Centric, Software Centric), By Medication (Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Medication Adherence Market, valued at USD 2.66 Billion in 2024, is projected to experience a CAGR of 5.30% to reach USD 3.63 Billion by 2030. Medication adherence solutions encompass techn...
November 2025
187 pages
Atopic Dermatitis Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Class (Biologics, PDE4 Inhibitors, Corticosteroids, Calcineurin Inhibitors), By Route of Administration (Topical, Injectable, Oral), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Atopic Dermatitis Drugs Market, valued at USD 14.52 Billion in 2024, is projected to experience a CAGR of 8.83% to reach USD 24.12 Billion by 2030. The global atopic dermatitis drugs market...
November 2025
185 pages
CBD Consumer Health Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Medical OTC Products, Nutraceuticals), By Distribution Channel (Retail Pharmacies, Retail Stores, Online), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global CBD Consumer Health Market, valued at USD 16.92 Billion in 2024, is projected to experience a CAGR of 8.18% to reach USD 27.12 Billion by 2030. The Global CBD Consumer Health Market encompa...
November 2025
187 pages
Infectious Disease Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Disease Type (HIV, Hepatitis, Influenza, TB, Malaria, HPV, Others), By End Use (Hospitals, Clinics, Others), By Region, and By Competition, 2020-2030F
US$ 4,500.00
The Global Infectious Disease Therapeutics Market, valued at USD 67.64 Billion in 2024, is projected to experience a CAGR of 7.74% to reach USD 105.80 Billion by 2030. The Global Infectious Disease Th...
November 2025
185 pages
Sleeping Aids Market - Global Industry Size, Share, Trends, Opportunity, and Forecast,egmented By Product Type (Mattresses & Pillows, Medications, Sleep Apnea Devices and Others), By Sleep Disorder (Insomnia, Narcolepsy, Restless Leg Syndrome, Sleep Apnea and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, E-commerce, Drug Stores and Others), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Sleeping Aids Market, valued at USD 66.52 Billion in 2024, is projected to experience a CAGR of 6.45% to reach USD 96.79 Billion by 2030. Sleeping aids encompass a broad spectrum of pharmac...
November 2025
187 pages
Inflammatory Bowel Disease (IBD) Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Class (TNF Inhibitors, Corticosteroids, Amino Salicylates, Immunomodulators, Others), By Disease Indication (Ulcerative Colitis, Crohn’s Disease), By Route of Administration (Oral, Injectable), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Vision Positioning System Market, valued at USD 7.39 Billion in 2024, is projected to experience a CAGR of 13.81% to reach USD 16.06 Billion by 2030. A Vision Positioning System (VPS) is a...
November 2025
190 pages
Fill-Finish Manufacturing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Consumables, Instrument), By End User (Contract Manufacturing Organizations (CMO), Pharmaceutical & Biopharmaceutical Companies, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Fill-Finish Manufacturing Market , valued at USD 17.45 Billion in 2024, is projected to experience a CAGR of 9.41% to reach USD 29.93 Billion by 2030. Fill-finish manufacturing represents t...
November 2025
180 pages
Me Too Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Class (Beta Blockers, Antidepressants, Statins, Proton Pump Inhibitors, Benzodiazepines, Others), By Therapeutic Area (Oncology, Diabetes, Hepatitis C, Cardiovascular, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Me Too Drugs Market, valued at USD 384.81 Million in 2024, is projected to experience a CAGR of 5.87% to reach USD 541.86 Million by 2030. 'Me Too' drugs, also recognized as follow-on or in...
November 2025
185 pages
Nuclear Pharmacy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Institutional and Commercial), By Purpose (Diagnostic and Therapeutic), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Nuclear Pharmacy Market, valued at USD 5.99 Billion in 2024, is projected to experience a CAGR of 7.92% to reach USD 9.46 Billion by 2030. Nuclear pharmacy involves the preparation and disp...
November 2025
185 pages
Beyond The Pill Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Therapeutic Area (Diabetes, Oncology, Cardiovascular Diseases, Asthma, Others), By Offerings (Services, Monitoring, Assistance, Information, Education), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Beyond The Pill Market will grow from USD 282.44 Million in 2024 to USD 416.44 Million by 2030 at a 6.69% CAGR. The 'Global Beyond The Pill Market' encompasses innovative digital health sol...
November 2025
185 pages
Infantile Spasm Therapeutics Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Therapeutic Class (Anticonvulsants, Corticosteroids, Others), By Drug Type (Vigabatrin, Adrenocorticotropic Hormone, Others (Phase III)), By Dosage (Solid, Liquid), by Region, and Competition, 2020-2030F
US$ 4,500.00
The Global Infantile Spasm Therapeutics Market , valued at USD 3.32 Billion in 2024, is projected to experience a CAGR of 4.04% to reach USD 4.21 Billion by 2030. Infantile spasm therapeutics comprise...
November 2025
182 pages
Precision Dosing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Patient Type (Pediatrics, Geriatrics, Patients on Polypharmacy, Patients with End Organ Dysfunction, Others), By Tools (Physiologically-Based Pharmacokinetic (PBPK) Modeling and Non-Linear Mixed Effects (NLME) Modeling), By Software (Web-Based and Desktop-Based), By Drug Class (Antibiotics, Antimycotics, Immunosuppressives, Antiepileptics, Antitumoral Drugs, Antidepressants, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Precision Dosing Market, valued at USD 188.34 Million in 2024, is projected to experience a CAGR of 7.72% to reach USD 294.33 Million by 2030. Precision dosing involves the accurate and con...
November 2025
185 pages
Bleeding Disorders Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Type (Plasma-derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Desmopressin, Antifibrinolytics, Fibrin Sealants, Others), By Disease Type (Hemophilia A, Hemophilia B, Von Willebrand Disease, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online), By End User (Hospitals, Hemophilia Treatment Centers, Research Institutes, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Bleeding Disorders Drugs Market, valued at USD 6.03 Billion in 2024, is projected to experience a CAGR of 6.78% to reach USD 8.94 Billion by 2030. Bleeding disorders drugs are pharmaceutica...
November 2025
185 pages
Lysosomal Disease Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Disease Type (Mucopolysaccharidosis, Pompes Syndrome, Fabry Diseases, Gaucher's Disease, Other), By Therapy (Substrate Reduction Therapy, Stem Cell Therapy, Enzyme Replacement Therapy, Other), By Route Of Administration (Oral, Parenteral, Other), By End User (Hospitals, Specialty Clinics, Homecare, Other), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Lysosomal Disease Treatment Market, valued at USD 8.10 Billion in 2024, is projected to experience a CAGR of 7.10% to reach USD 12.22 Billion by 2030. The Global Lysosomal Disease Treatment...
November 2025
185 pages
Anti-Viral Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Branded, Generics), By Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Application (HIV, Hepatitis, Herpes, Influenza, Others) By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Anti-Viral Drugs Market, valued at USD 77.10 Billion in 2024, is projected to experience a CAGR of 3.89% to reach USD 96.94 Billion by 2030. Antiviral drugs are pharmaceutical agents develo...
November 2025
181 pages
Monkeypox Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment (Smallpox Vaccine, Antivirals, Vaccinia Immune Globulin (VIG)), By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others), By Region and Competition, 2020-2030F
US$ 4,500.00
The Global Monkeypox Therapeutics Market, valued at USD 87.00 Million in 2024, is projected to experience a CAGR of 9.01% to reach USD 145.99 Million by 2030. Monkeypox therapeutics encompass pharmace...
November 2025
185 pages
Hirschsprung Disease Treatment Market 2026
US$ 2,999.00
The Hirschsprung Disease Treatment Market was valued at in and is anticipated to reach by , at a CAGR of 0.06 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, includi...
November 2025
219 pages
